0
ARTICLE |

Cyclosporine-Ketoconazole Combination Offers Promise in Reducing Antirejection Therapy Costs

Teri Randall
JAMA. 1990;264(4):430-431. doi:10.1001/jama.1990.03450040018004.
Text Size: A A A
Published online

ABSTRACT

RESEARCHERS have wed the prince of immunosuppressive drugs, cyclosporine, to a common antifungal medication, ketoconazole, and this union has been shown to slash the costs of antirejection therapy in patients who have undergone kidney transplantation by more than 80%.

Historically, Sandoz Pharmaceuticals Corporation (East Hanover, NJ), the manufacturer of cyclosporine, has discouraged the concomitant use of ketoconazole (Nizoral, Janssen Pharmaceutica Inc, Piscataway, NJ) because it creates dangerously high cyclosporine levels in the blood. But the kidney transplant team at the University of Cincinnati (Ohio) reports it has harnessed this property of ketoconazole to allow a reduction in the cyclosporine dosage by 70% in the first week and up to 88% after 18 months.

"If found to be safe and effective, this drug interaction has enormous potential for reductions in the costs associated with organ transplantation," says Roy First, MD, director of the University of Cincinnati Medical Center's kidney transplantation section.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();